English
Everything For Better Medical Care
—— Ziweishan Pharmaceutical
Hebei Ziweishan Pharmaceutical Co., Ltd. was founded in 1988 by Li Huisheng, a representative of the Eighth National People's Congress and a national labor model. It has a registered capital of 34.2 million yuan. It is a high-tech enterprise integrating R&D, production and sales.
Ziweishan Pharmaceutical began to develop artificial kidney dialysis powder in 1993, filling the domestic gap. It is the leading domestic manufacturer of registered hemodialysis products and has won gold medals from the national and provincial governments. In 2002, it passed the GB/T19001 (ISO9001) quality system certification and YY/T0287 (ISO13485) certification, and is a well-known brand product in the same industry. Pharmaceutical production is divided into three dosage forms: tablets, hard capsules, and granules. It has an independent traditional Chinese medicine extraction production line. It passed the GMP certification as a whole in June 2004 and passed the new national GMP certification in 2017.
1988
Founded in 1988
120000
The factory covers an area of 120,000 square meters
1000+
Number of cooperation 1000+
Hebei Ziweishan Pharmaceutical provides high-purity hemodialysis concentrated powder, which complies with GMP standards, has few impurities, high safety, low acetate content, and is suitable for long-term dialysis and concentration For liquid use. To meet the efficient and safe dialysis needs of medical institutions across the country, consultation
Hebei Ziweishan Pharmaceutical provides a variety of formulas of hemodialysis concentrates, including high-calcium, low-calcium, high-potassium, and sugar-containing formulas, which meet ultra-pure dialysate standards and are suitable for a variety of dialysis machine models to meet the individual needs of different patients. Safe and stable, welco
Composed of pure cotton non-woven fabric, double long-chain quaternary ammonium salts and purified water. The active ingredient is didecyldimethylammonium chloride, with a content of 0.28-0.32%.
We are committed to pursuing transformative innovation and bringing smarter and more personalized treatment options to patients.
We are committed to pursuing transformative innovation and bringing smarter and more personalized treatment options to patients.
We are committed to pursuing transformative innovation and bringing smarter and more personalized treatment options to patients.
Committed to contributing to medical public services
We believe that everyone should stay away from diseases, live a healthy life, and make life full of possibilities. We are committed to pursuing transformative innovation and bringing smarter and more personalized treatment options to patients.
Customer Network
We always adhere to the corporate mission of saving and extending lives, continue to innovate on the cutting edge, and work together with medical professionals. We are committed to improving patient outcomes and helping our partners address the ever-changing challenges and opportunities in healthcare around the world.
Sold Nationwide
34 Provinces
Nov. 04, 2024
With the popularity of hemodialysis treatment, the selection of hemodialysis concentrate has gradually become a focus of attention for patients and medical institutions. Choosing the appropriate dialysis concentrate can not only effectively remove metabolic waste, but also reduce the risk of adverse reactions.
Nov. 03, 2024
Hemodialysis market demand continues to grow, and the industry has broad prospects for development
In recent years, the global hemodialysis market has continued to expand, mainly driven by the increasing prevalence of chronic kidney disease and the aging trend.
Oct. 08, 2024
In February 2024, Hebei Ziweishan Pharmaceutical Co., Ltd. was rated as an "Excellent Private Enterprise" by the Baoding Municipal Party Committee and Municipal Government. This is a sign of the company's success in hemodialysis Highly recognized for contributions to the product and medical device fields.
